Literature DB >> 18726879

The eligibility for local-regional treatment of peritoneal surface malignancy.

Vic J Verwaal1, Shigeki Kusamura, Dario Baratti, Marcello Deraco.   

Abstract

At the Fifth International Workshop on Peritoneal Surface Malignancy, held in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. General conflicting points concerning the eligibility to the local-regional therapy were discussed and voted.

Entities:  

Mesh：

Year:  2008        PMID： 18726879     DOI： 10.1002/jso.21060

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  11 in total

Review 1.  Cytoreductive Surgery and Peritonectomy Procedures.

Authors:  Sanket S Mehta; Aditi Bhatt; Olivier Glehen
Journal:  Indian J Surg Oncol       Date:  2016-02-03

2.  Role of Imaging in Peritoneal Surface Malignancies.

Authors:  Santosh Krishnamurthy; Raghav Balasubramaniam
Journal:  Indian J Surg Oncol       Date:  2016-06-08

3.  Selection of patients and staging of peritoneal surface malignancies.

Authors:  Eddy Cotte; Guillaume Passot; François-Noël Gilly; Olivier Glehen
Journal:  World J Gastrointest Oncol       Date:  2010-01-15

Review 4.  Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.

Authors:  Aaron H Colby; Nicholas H Oberlies; Cedric J Pearce; Victoria L M Herrera; Yolonda L Colson; Mark W Grinstaff
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-09

Review 5.  Role of surgery in colorectal cancer liver metastases.

Authors:  Özgür Akgül; Erdinç Çetinkaya; Şiyar Ersöz; Mesut Tez
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

6.  Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.

Authors:  Charlotte E L Klaver; Gijsbert D Musters; Willem A Bemelman; Cornelis J A Punt; Victor J Verwaal; Marcel G W Dijkgraaf; Arend G J Aalbers; Jarmila D W van der Bilt; Djamila Boerma; Andre J A Bremers; Jacobus W A Burger; Christianne J Buskens; Pauline Evers; Robert J van Ginkel; Wilhelmina M U van Grevenstein; Patrick H J Hemmer; Ignace H J T de Hingh; Laureen A Lammers; Barbara L van Leeuwen; Wilhelmus J H J Meijerink; Simon W Nienhuijs; Jolien Pon; Sandra A Radema; Bert van Ramshorst; Petur Snaebjornsson; Jurriaan B Tuynman; Elisabeth A Te Velde; Marinus J Wiezer; Johannes H W de Wilt; Pieter J Tanis
Journal:  BMC Cancer       Date:  2015-05-24       Impact factor: 4.430

Review 7.  Treatment of peritoneal metastases from colorectal cancer.

Authors:  Loreen März; Pompiliu Piso
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-09-30

8.  Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  N R Sluiter; E M V de Cuba; R Kwakman; W J H J Meijerink; P M Delis-van Diemen; V M H Coupé; J A M Beliën; G A Meijer; I H J T de Hingh; E A te Velde
Journal:  Clin Exp Metastasis       Date:  2016-02-12       Impact factor: 5.150

Review 9.  Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy.

Authors:  James R W McMullen; Matthew Selleck; Nathan R Wall; Maheswari Senthil
Journal:  Oncotarget       Date:  2017-06-27

Review 10.  Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options.

Authors:  Nina Sluiter; Erienne de Cuba; Riom Kwakman; Geert Kazemier; Gerrit Meijer; Elisabeth Atie Te Velde
Journal:  Clin Exp Metastasis       Date:  2016-04-13       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.